SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Bright Health Group, Inc. (BHG) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+510.6%).
- 分析师共识目标价 $99.84 (+510.6% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 35/100 其中 1/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — BHG
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.14
EV/EBITDA0.0
每股数据
EPS (TTM)$-22.65
每股账面价值$0.00
每股营收$113.87
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$99.84 (+510.6%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2018 |
$-37.97 |
$130.63M |
$-62.64M |
-48% |
| 2019 |
$-79.52 |
$280.67M |
$-133.69M |
-47.6% |
| 2020 |
$-145.94 |
$1.21B |
$-248.44M |
-20.6% |
| 2021 |
$-240.33 |
$4.03B |
$-1.18B |
-29.2% |
| 2022 |
$-81.08 |
$2.41B |
$-637.97M |
-26.4% |
| 2023 |
$-150.94 |
$1.16B |
$-1.2B |
-103.4% |
| 2024 |
$-22.65 |
$936.66M |
$-186.33M |
-19.9% |
